This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

On questions about PrEP for the "at risk" to ask their health care providers: "PrEP is only for HIV-negative people. So, the first thing to ask a provider for is an HIV test. It’s good to review ...

Black men who were identified as sexual minorities were more receptive to long-acting injectable pre-exposure prophylaxis ...

HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally ...

In a case with significant implications for the future of HIV prevention, the US Supreme Court ruled 6-3 to uphold a provision of the Affordable Care Act that determines which preventive services ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a year.

The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most ...

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo. Phase 3 trials showed ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking studies, Gilead Sciences’ shot, a drug named lenacapavir, nearly eliminated new ...

The NC State basketball staff may be close to entering the Qayden Samuels sweepstakes.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

President Cyril Ramaphosa says there should be sufficient funding for the after effects of climate change, such as floods. Ramaphosa wrapped up his working visit in Kananaskis, Canada, yesterday, ...